Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis?

Abstract

A male neonate with hyperbilirubinaemia and progressing anaemia due to rhesus (c+E) incompatibility received high dose intravenous gammaglobulin (ivIgG) therapy at 13 days of age. Clinical response to therapy was confirmed by a rapid decrease in serum bilirubin level, and with the prevention of a further decline of the haemoglobin level. No side-effects were noted. High dose ivIgG therapy could be an alternative to (exchange) blood transfusion in case of some haemolytic diseases of newborn.

DOI: 10.1007/BF01958434

1 Figure or Table

Cite this paper

@article{Kubo1991CanHI, title={Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis?}, author={Satomi Kubo and Takashi Ariga and H. Tsuneta and Tsutomu Ishii}, journal={European Journal of Pediatrics}, year={1991}, volume={150}, pages={507-508} }